1. Activated tumor cell integrin αvβ3 cooperates with platelets to promote extravasation and metastasis from the blood stream. Weber MR, Zuka M, Lorger M, Tschan M, Torbett BE, Zijlstra A, Quigley JP, Staflin K, Eliceiri BP, Krueger JS, Marchese P, Ruggeri ZM, Felding BH (2016) Thromb Res : S27-36
    › Primary publication · 27067975 (PubMed) · PMC4888909 (PubMed Central)
  2. TRIzol and Alu qPCR-based quantification of metastatic seeding within the skeleton. Preston Campbell J, Mulcrone P, Masood SK, Karolak M, Merkel A, Hebron K, Zijlstra A, Sterling J, Elefteriou F (2015) Sci Rep : 12635
    › Primary publication · 26271202 (PubMed) · PMC4536516 (PubMed Central)
  3. Small molecule/ML327 mediated transcriptional de-repression of E-cadherin and inhibition of epithelial-to-mesenchymal transition. An H, Stoops SL, Deane NG, Zhu J, Zi J, Weaver C, Waterson AG, Zijlstra A, Lindsley CW, Beauchamp RD (2015) Oncotarget 6(26): 22934-48
    › Primary publication · 26082441 (PubMed) · PMC4673210 (PubMed Central)
  4. Intrinsic TGF-β2-triggered SDF-1-CXCR4 signaling axis is crucial for drug resistance and a slow-cycling state in bone marrow-disseminated tumor cells. Nakamura T, Shinriki S, Jono H, Guo J, Ueda M, Hayashi M, Yamashita S, Zijlstra A, Nakayama H, Hiraki A, Shinohara M, Ando Y (2015) Oncotarget 6(2): 1008-19
    › Primary publication · 25504440 (PubMed) · PMC4359213 (PubMed Central)
  5. High efficacy vasopermeability drug candidates identified by screening in an ex ovo chorioallantoic membrane model. Pink D, Luhrs KA, Zhou L, Schulte W, Chase J, Frosch C, Haberl U, Nguyen V, Roy AI, Lewis JD, Zijlstra A, Parseghian MH (2015) Sci Rep : 15756
    › Primary publication · 26510887 (PubMed) · PMC4625159 (PubMed Central)
  6. Directional cell movement through tissues is controlled by exosome secretion. Sung BH, Ketova T, Hoshino D, Zijlstra A, Weaver AM (2015) Nat Commun : 7164
    › Primary publication · 25968605 (PubMed) · PMC4435734 (PubMed Central)
  7. Transforming growth factor beta receptor type III is a tumor promoter in mesenchymal-stem like triple negative breast cancer. Jovanović B, Beeler JS, Pickup MW, Chytil A, Gorska AE, Ashby WJ, Lehmann BD, Zijlstra A, Pietenpol JA, Moses HL (2014) Breast Cancer Res 16(4): R69
    › Primary publication · 24985072 (PubMed) · PMC4095685 (PubMed Central)
  8. The chick embryo as an expanding experimental model for cancer and cardiovascular research. Kain KH, Miller JW, Jones-Paris CR, Thomason RT, Lewis JD, Bader DM, Barnett JV, Zijlstra A (2014) Dev Dyn 243(2): 216-28
    › Primary publication · 24357262 (PubMed) · PMC4164046 (PubMed Central)
  9. Techniques and assays for the study of angiogenesis. Irvin MW, Zijlstra A, Wikswo JP, Pozzi A (2014) Exp Biol Med (Maywood) 239(11): 1476-88
    › Primary publication · 24872440 (PubMed) · PMC4216737 (PubMed Central)
  10. Metastasis as a therapeutic target in prostate cancer: a conceptual framework. Stoletov K, Bond D, Hebron K, Raha S, Zijlstra A, Lewis JD (2014) Am J Clin Exp Urol 2(1): 45-56
    › Primary publication · 25360439 (PubMed) · PMC4219290 (PubMed Central)